Follow
Yaacov Richard Lawrence
Yaacov Richard Lawrence
Director, Center for Translational Research in Radiation Oncology, Sheba Medical Center, Israel
Verified email at sheba.health.gov.il
Title
Cited by
Cited by
Year
Radiation dose–volume effects in the brain
YR Lawrence, XA Li, I El Naqa, CA Hahn, LB Marks, TE Merchant, ...
International Journal of Radiation Oncology* Biology* Physics 76 (3), S20-S27, 2010
8732010
Patient-oriented cancer information on the internet: a comparison of wikipedia and a professionally maintained database
MS Rajagopalan, VK Khanna, Y Leiter, M Stott, TN Showalter, AP Dicker, ...
Journal of Oncology Practice 7 (5), 319-323, 2011
1282011
Cancer of unknown primary: a population-based analysis of temporal change and socioeconomic disparities
D Urban, A Rao, M Bressel, YR Lawrence, L Mileshkin
British journal of cancer 109 (5), 1318-1324, 2013
782013
Delayed initiation of radiotherapy for glioblastoma: how important is it to push to the front (or the back) of the line?
YR Lawrence, DT Blumenthal, D Matceyevsky, AA Kanner, F Bokstein, ...
Journal of neuro-oncology 105, 1-7, 2011
762011
Quality assurance peer review chart rounds in 2011: A survey of academic institutions in the United States
YR Lawrence, MA Whiton, Z Symon, EJ Wuthrick, L Doyle, AS Harrison, ...
International Journal of Radiation Oncology* Biology* Physics 84 (3), 590-595, 2012
732012
Splenic infarction: an update on William Osler's observations.
MA Lawrence, YR MBBS MRCP, MB Pokroy, MB Berlowitz, MD Aharoni, ...
712010
NCI–RTOG translational program strategic guidelines for the early-stage development of radiosensitizers
YR Lawrence, B Vikram, JJ Dignam, A Chakravarti, M Machtay, B Freidlin, ...
Journal of the National Cancer Institute 105 (1), 11-24, 2013
642013
Improving prognosis of glioblastoma in the 21st century: who has benefited most?
YR Lawrence, MV Mishra, M Werner‐Wasik, DW Andrews, TN Showalter, ...
Cancer 118 (17), 4228-4234, 2012
592012
Does choline PET/CT change the management of prostate cancer patients with biochemical failure?
J Goldstein, E Even-Sapir, S Ben-Haim, A Saad, B Spieler, T Davidson, ...
American Journal of Clinical Oncology 40 (3), 256-259, 2017
562017
Changing prognosis of metastatic colorectal adenocarcinoma: Differential improvement by age and tumor location
T Golan, D Urban, R Berger, YR Lawrence
Cancer 119 (16), 3084-3091, 2013
562013
Eukaryotic Initiation Factor 2α-a Downstream Effector of Mammalian Target of Rapamycin-Modulates DNA Repair and Cancer Response to Treatment
L Tuval-Kochen, S Paglin, G Keshet, Y Lerenthal, C Nakar, T Golani, ...
PloS one 8 (10), e77260, 2013
542013
Short-and long-term survival in metastatic pancreatic adenocarcinoma, 1993–2013
T Golan, T Sella, O Margalit, U Amit, N Halpern, D Aderka, ...
Journal of the National Comprehensive Cancer Network 15 (8), 1022-1027, 2017
532017
Phase I trial of panobinostat and fractionated stereotactic re-irradiation therapy for recurrent high grade gliomas
W Shi, JD Palmer, M Werner-Wasik, DW Andrews, JJ Evans, J Glass, ...
Journal of neuro-oncology 127, 535-539, 2016
522016
Characterization and outcomes of optic nerve gliomas: a population-based analysis
MV Mishra, DW Andrews, J Glass, JJ Evans, AP Dicker, X Shen, ...
Journal of neuro-oncology 107, 591-597, 2012
502012
Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trial
W Shi, YR Lawrence, H Choy, M Werner-Wasik, DW Andrews, JJ Evans, ...
Journal of neuro-oncology 118, 313-319, 2014
482014
Predictors of radiation oncology resident research productivity
JM Gutovich, RB Den, M Werner-Wasik, AP Dicker, YR Lawrence
Journal of the American College of Radiology 10 (3), 185-189, 2013
482013
A phase I study of the combination of sorafenib with temozolomide and radiation therapy for the treatment of primary and recurrent high-grade gliomas
RB Den, M Kamrava, Z Sheng, M Werner-Wasik, E Dougherty, ...
International Journal of Radiation Oncology* Biology* Physics 85 (2), 321-328, 2013
472013
Lymph node ratio predicts the benefit of post-operative radiotherapy in oral cavity cancer
D Urban, I Gluck, MR Pfeffer, Z Symon, YR Lawrence
Radiotherapy and Oncology 106 (1), 74-79, 2013
472013
mTOR is a selective effector of the radiation therapy response in androgen receptor-positive prostate cancer
MJ Schiewer, R Den, DT Hoang, MA Augello, YR Lawrence, AP Dicker, ...
Endocrine-related cancer 19 (1), 1, 2012
472012
Early toxicity predicts long-term survival in high-grade glioma
YR Lawrence, M Wang, AP Dicker, D Andrews, WJ Curran, JM Michalski, ...
British journal of cancer 104 (9), 1365-1371, 2011
472011
The system can't perform the operation now. Try again later.
Articles 1–20